{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:42:36Z","timestamp":1791333756631,"version":"4.3.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vaccine Company, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67969-x","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:17:31Z","timestamp":1767493051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-8847","authenticated-orcid":false,"given":"Ryan S.","family":"McCool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory M.","family":"Acreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6408-9495","authenticated-orcid":false,"given":"Abigail E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia I.","family":"Picucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8523-1528","authenticated-orcid":false,"given":"Daniel J.","family":"Stieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-338X","authenticated-orcid":false,"given":"Chia-Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-411X","authenticated-orcid":false,"given":"Soyoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"O\u2019Rear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad A.","family":"Palanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-8951","authenticated-orcid":false,"given":"Patrick O.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline R.","family":"Sponholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongryeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Ledgerwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payton A.-B.","family":"Weidenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":false,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"67969_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","volume":"148","author":"Y Wong","year":"2022","unstructured":"Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L. & Miles, J. J. Estimating the global burden of Epstein\u2013Barr virus-related cancers. J. Cancer Res. Clin. Oncol. 148, 31\u201346 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"67969_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"67969_CR3","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","volume":"186","author":"H Vietzen","year":"2023","unstructured":"Vietzen, H. et al. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis. Cell 186, 5705\u20135718.e5713 (2023).","journal-title":"Cell"},{"key":"67969_CR4","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1074\/jbc.M116.721746","volume":"291","author":"I Bagdonaite","year":"2016","unstructured":"Bagdonaite, I. et al. Global mapping of O-glycosylation of Varicella Zoster virus, human cytomegalovirus, and Epstein\u2013Barr virus. J. Biol. Chem. 291, 12014\u201312028 (2016).","journal-title":"J. Biol. Chem."},{"key":"67969_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.virol.2007.06.031","volume":"368","author":"M Backovic","year":"2007","unstructured":"Backovic, M., Leser, G. P., Lamb, R. A., Longnecker, R. & Jardetzky, T. S. Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins. Virology 368, 102\u2013113 (2007).","journal-title":"Virology"},{"key":"67969_CR6","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1073\/pnas.0810530106","volume":"106","author":"M Backovic","year":"2009","unstructured":"Backovic, M., Longnecker, R. & Jardetzky, T. S. Structure of a trimeric variant of the Epstein\u2013Barr virus glycoprotein B. Proc. Natl. Acad. Sci. USA 106, 2880\u20132885 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1099\/vir.0.007237-0","volume":"90","author":"J Sorem","year":"2009","unstructured":"Sorem, J. & Longnecker, R. Cleavage of Epstein\u2013Barr virus glycoprotein B is required for full function in cell\u2013cell fusion with both epithelial and B cells. J. Gen. Virol. 90, 591\u2013595 (2009).","journal-title":"J. Gen. Virol."},{"key":"67969_CR8","doi-asserted-by":"publisher","first-page":"16286","DOI":"10.1073\/pnas.0407320101","volume":"101","author":"E Johannsen","year":"2004","unstructured":"Johannsen, E. et al. Proteins of purified Epstein\u2013Barr virus. Proc. Natl. Acad. Sci. USA 101, 16286\u201316291 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-virology-111821-093413","volume":"10","author":"JM White","year":"2023","unstructured":"White, J. M., Ward, A. E., Odongo, L. & Tamm, L. K. Viral membrane fusion: a dance between proteins and lipids. Annu. Rev. Virol. 10, 139\u2013161 (2023).","journal-title":"Annu. Rev. Virol."},{"key":"67969_CR10","doi-asserted-by":"publisher","first-page":"e1007452","DOI":"10.1371\/journal.ppat.1007452","volume":"14","author":"Z Si","year":"2018","unstructured":"Si, Z. et al. Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate. PLoS Pathog. 14, e1007452 (2018).","journal-title":"PLoS Pathog."},{"key":"67969_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf3178","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. Sci. Adv. 7, eabf3178 (2021).","journal-title":"Sci. Adv."},{"key":"67969_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1128\/JVI.72.1.158-163.1998","volume":"72","author":"X Wang","year":"1998","unstructured":"Wang, X. & Hutt-Fletcher, L. M. Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J. Virol. 72, 158\u2013163 (1998).","journal-title":"J. Virol."},{"key":"67969_CR13","doi-asserted-by":"publisher","first-page":"20464","DOI":"10.1073\/pnas.0907508106","volume":"106","author":"LS Chesnokova","year":"2009","unstructured":"Chesnokova, L. S., Nishimura, S. L. & Hutt-Fletcher, L. M. Fusion of epithelial cells by Epstein\u2013Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins \u03b1v\u03b26 or \u03b1v\u03b28. Proc. Natl. Acad. Sci. USA 106, 20464\u201320469 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR14","doi-asserted-by":"publisher","first-page":"12193","DOI":"10.1128\/JVI.01597-14","volume":"88","author":"LS Chesnokova","year":"2014","unstructured":"Chesnokova, L. S., Ahuja, M. K. & Hutt-Fletcher, L. M. Epstein\u2013Barr virus glycoprotein gB and gHgL can mediate fusion and entry in trans, and heat can act as a partial surrogate for gHgL and trigger a conformational change in gB. J. Virol. 88, 12193\u201312201 (2014).","journal-title":"J. Virol."},{"key":"67969_CR15","doi-asserted-by":"publisher","first-page":"17474","DOI":"10.1073\/pnas.0404535101","volume":"101","author":"MP McShane","year":"2004","unstructured":"McShane, M. P. & Longnecker, R. Cell-surface expression of a mutated Epstein\u2013Barr virus glycoprotein B allows fusion independent of other viral proteins. Proc. Natl. Acad. Sci. USA 101, 17474\u201317479 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2018.03.026","volume":"48","author":"J Snijder","year":"2018","unstructured":"Snijder, J. et al. An antibody targeting the fusion machinery neutralizes dual-tropic infection and defines a site of vulnerability on Epstein\u2013Barr virus. Immunity 48, 799\u2013811. e799 (2018).","journal-title":"Immunity"},{"key":"67969_CR17","doi-asserted-by":"publisher","unstructured":"Zhang, X. et al. Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion. Proc. Natl. Acad. Sci. USA 119, https:\/\/doi.org\/10.1073\/pnas.2202371119 (2022).","DOI":"10.1073\/pnas.2202371119"},{"key":"67969_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"67969_CR19","doi-asserted-by":"publisher","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","volume":"114","author":"J Pallesen","year":"2017","unstructured":"Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. USA 114, E7348\u2013E7357 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade0424","volume":"14","author":"LA Chang","year":"2022","unstructured":"Chang, L. A. et al. A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine. Sci. Transl. Med. 14, eade0424 (2022).","journal-title":"Sci. Transl. Med."},{"key":"67969_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28931-3","volume":"13","author":"C-L Hsieh","year":"2022","unstructured":"Hsieh, C.-L. et al. Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins. Nat. Commun. 13, 1299 (2022).","journal-title":"Nat. Commun."},{"key":"67969_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48059-w","volume":"15","author":"JP Langedijk","year":"2024","unstructured":"Langedijk, J. P. et al. Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Nat. Commun. 15, 4629 (2024).","journal-title":"Nat. Commun."},{"key":"67969_CR23","doi-asserted-by":"publisher","first-page":"12265","DOI":"10.1073\/pnas.1811980115","volume":"115","author":"GB Stewart-Jones","year":"2018","unstructured":"Stewart-Jones, G. B. et al. Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1\u20134. Proc. Natl. Acad. Sci. USA 115, 12265\u201312270 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/289366a0","volume":"289","author":"IA Wilson","year":"1981","unstructured":"Wilson, I. A., Skehel, J. J. & Wiley, D. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3\u2009\u00c5 resolution. Nature 289, 366\u2013373 (1981).","journal-title":"Nature"},{"key":"67969_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nature04322","volume":"439","author":"H-S Yin","year":"2006","unstructured":"Yin, H.-S., Wen, X., Paterson, R. G., Lamb, R. A. & Jardetzky, T. S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439, 38\u201344 (2006).","journal-title":"Nature"},{"key":"67969_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41586-020-2333-6","volume":"583","author":"DJ Benton","year":"2020","unstructured":"Benton, D. J., Gamblin, S. J., Rosenthal, P. B. & Skehel, J. J. Structural transitions in influenza haemagglutinin at membrane fusion pH. Nature 583, 150\u2013153 (2020).","journal-title":"Nature"},{"key":"67969_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo3153","volume":"8","author":"TC Marcink","year":"2022","unstructured":"Marcink, T. C. et al. Intermediates in SARS-CoV-2 spike-mediated cell entry. Sci. Adv. 8, eabo3153 (2022).","journal-title":"Sci. Adv."},{"key":"67969_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.cell.2025.01.012","volume":"188","author":"L Xing","year":"2025","unstructured":"Xing, L. et al. Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target. Cell 188, 1297\u20131314.e1224 (2025).","journal-title":"Cell"},{"key":"67969_CR29","doi-asserted-by":"publisher","unstructured":"Sponholtz, M. R. et al. Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation. Proc. Natl. Acad. Sci. USA 121, https:\/\/doi.org\/10.1073\/pnas.2404250121 (2024).","DOI":"10.1073\/pnas.2404250121"},{"key":"67969_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1128\/jvi.61.2.499-508.1987","volume":"61","author":"M Gong","year":"1987","unstructured":"Gong, M., Ooka, T., Matsuo, T. & Kieff, E. Epstein\u2013Barr virus glycoprotein homologous to herpes simplex virus gB. J. Virol. 61, 499\u2013508 (1987).","journal-title":"J. Virol."},{"key":"67969_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"67969_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"67969_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314853121","volume":"121","author":"H Dieckhaus","year":"2024","unstructured":"Dieckhaus, H., Brocidiacono, M., Randolph, N. Z. & Kuhlman, B. Transfer learning to leverage larger datasets for improved prediction of protein stability changes. Proc. Natl. Acad. Sci. USA 121, e2314853121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67969_CR34","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.coi.2022.102209","volume":"77","author":"PO Byrne","year":"2022","unstructured":"Byrne, P. O. & McLellan, J. S. Principles and practical applications of structure-based vaccine design. Curr. Opin. Immunol. 77, 102209 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"67969_CR35","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1128\/JVI.00758-07","volume":"81","author":"M Backovic","year":"2007","unstructured":"Backovic, M., Jardetzky, T. S. & Longnecker, R. Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity. J. Virol. 81, 9596\u20139600 (2007).","journal-title":"J. Virol."},{"key":"67969_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pro.3290","volume":"27","author":"F Sievers","year":"2018","unstructured":"Sievers, F. & Higgins, D. G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 27, 135\u2013145 (2018).","journal-title":"Protein Sci."},{"key":"67969_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.1126548","volume":"313","author":"EE Heldwein","year":"2006","unstructured":"Heldwein, E. E. et al. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313, 217\u2013220 (2006).","journal-title":"Science"},{"key":"67969_CR38","doi-asserted-by":"publisher","first-page":"e1005227","DOI":"10.1371\/journal.ppat.1005227","volume":"11","author":"HG Burke","year":"2015","unstructured":"Burke, H. G. & Heldwein, E. E. Crystal structure of the human cytomegalovirus glycoprotein B. PLoS Pathog. 11, e1005227 (2015).","journal-title":"PLoS Pathog."},{"key":"67969_CR39","doi-asserted-by":"publisher","first-page":"e01533","DOI":"10.1128\/jvi.01533-24","volume":"99","author":"F Ito","year":"2025","unstructured":"Ito, F. et al. Structure of the Kaposi\u2019s sarcoma-associated herpesvirus gB in post-fusion conformation. J. Virol. 99, e01533\u201301524 (2025).","journal-title":"J. Virol."},{"key":"67969_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nsmb.3267","volume":"23","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV. Nat. Struct. Mol. Biol. 23, 811\u2013820 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"67969_CR41","doi-asserted-by":"publisher","first-page":"W280","DOI":"10.1093\/nar\/gkae408","volume":"52","author":"N Felbinger","year":"2024","unstructured":"Felbinger, N., Ribeiro-Filho, H. V. & Pierce, B. G. Proscan: a structure-based proline design web server. Nucleic Acids Res. 52, W280\u2013W286 (2024).","journal-title":"Nucleic Acids Res."},{"key":"67969_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920467","volume":"13","author":"J Hong","year":"2022","unstructured":"Hong, J. et al. Glycoprotein B antibodies completely neutralize EBV infection of B Cells. Front. Immunol. 13, 920467 (2022).","journal-title":"Front. Immunol."},{"key":"67969_CR43","unstructured":"\u66fe\u6728\u5723, \u8d75., \u51af\u56fd\u5f00, \u5218\u5c97\u950b, \u5b54\u7965\u709c, \u8c22\u695a. A monoclonal antibody against gB antigen of Epstein\u2013Barr virus and its application in virus labeling. China patent (2023)."},{"key":"67969_CR44","unstructured":"\u66fe\u6728\u5723, \u8d75., \u51af\u56fd\u5f00, \u5434\u6538, \u535c\u56fd\u9f99, \u674e\u6dd1\u946b. A kind of neutralizing monoclonal antibody against Epstein\u2013Barr virus gB antigen and its application. China patent (2023)."},{"key":"67969_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"67969_CR46","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1016\/j.vaccine.2022.04.102","volume":"40","author":"F Li","year":"2022","unstructured":"Li, F. et al. A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments. Vaccine 40, 3638\u20133646 (2022).","journal-title":"Vaccine"},{"key":"67969_CR47","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","volume":"74","author":"SJ Molesworth","year":"2000","unstructured":"Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M. & Hutt-Fletcher, L. M. Epstein\u2013Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J. Virol. 74, 6324\u20136332 (2000).","journal-title":"J. Virol."},{"key":"67969_CR48","doi-asserted-by":"publisher","unstructured":"McCallum, M. & Veesler, D. Computational design of prefusion-stabilized Herpesvirus gB trimers. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.10.23.619923 (2024).","DOI":"10.1101\/2024.10.23.619923"},{"key":"67969_CR49","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1016\/j.vaccine.2013.04.071","volume":"31","author":"X Cui","year":"2013","unstructured":"Cui, X. et al. A novel tetrameric gp3501-470 as a potential Epstein\u2013Barr virus vaccine. Vaccine 31, 3039\u20133045 (2013).","journal-title":"Vaccine"},{"key":"67969_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep18848","volume":"6","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology. Sci. Rep. 6, 18848 (2016).","journal-title":"Sci. Rep."},{"key":"67969_CR51","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3390\/ijms20133158","volume":"20","author":"X Cui","year":"2019","unstructured":"Cui, X. et al. Immunization of rabbits with recombinant human cytomegalovirus trimeric versus monomeric gH\/gL protein elicits markedly higher titers of antibody and neutralization activity. Int. J. Mol. Sci. 20, 3158 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"67969_CR52","doi-asserted-by":"publisher","unstructured":"Wamhoff, E.-C. et al. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nat. Commun. 15, https:\/\/doi.org\/10.1038\/s41467-024-44869-0 (2024).","DOI":"10.1038\/s41467-024-44869-0"},{"key":"67969_CR53","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","volume":"31","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV. Cell Host Microbe 31, 1882\u20131897.e1810 (2023).","journal-title":"Cell Host Microbe"},{"key":"67969_CR54","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1016\/j.vaccine.2016.06.021","volume":"34","author":"X Cui","year":"2016","unstructured":"Cui, X. et al. Rabbits immunized with Epstein\u2013Barr virus gH\/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350. Vaccine 34, 4050\u20134055 (2016).","journal-title":"Vaccine"},{"key":"67969_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/vaccines8020169","volume":"8","author":"GM Escalante","year":"2020","unstructured":"Escalante, G. M. et al. A pentavalent Epstein\u2013Barr virus-like particle vaccine elicits high titers of neutralizing antibodies against Epstein\u2013Barr virus infection in immunized rabbits. Vaccines 8, 169 (2020).","journal-title":"Vaccines"},{"key":"67969_CR56","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.immuni.2024.02.008","volume":"57","author":"W Bu","year":"2024","unstructured":"Bu, W. et al. Epstein\u2013Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells. Immunity 57, 559\u2013573.e556 (2024).","journal-title":"Immunity"},{"key":"67969_CR57","doi-asserted-by":"crossref","unstructured":"Wei, C.-J. et al. A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice.  Sci. Transl. Med. 14, eabf3685 (2022).","DOI":"10.1126\/scitranslmed.abf3685"},{"key":"67969_CR58","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","volume":"50","author":"W Bu","year":"2019","unstructured":"Bu, W. et al. Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein\u2013Barr Virus in B cells and epithelial cells. Immunity 50, 1305\u20131316.e1306 (2019).","journal-title":"Immunity"},{"key":"67969_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100658","volume":"3","author":"H Malhi","year":"2022","unstructured":"Malhi, H. et al. Immunization with a self-assembling nanoparticle vaccine displaying EBV gH\/gL protects humanized mice against lethal viral challenge. Cell Rep. Med. 3, 100658 (2022).","journal-title":"Cell Rep. Med."},{"key":"67969_CR60","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."},{"key":"67969_CR61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"67969_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang, G. et al. EMAN2: An extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38\u201346 (2007).","journal-title":"J. Struct. Biol."},{"key":"67969_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"67969_CR64","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."},{"key":"67969_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"67969_CR66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"67969_CR67","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"67969_CR68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. Sect. D Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"67969_CR69","doi-asserted-by":"publisher","unstructured":"Powell, A. E. et al. A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.01.601243 (2024).","DOI":"10.1101\/2024.07.01.601243"},{"key":"67969_CR70","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the middle east respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape. J. Virol. 92, https:\/\/doi.org\/10.1128\/jvi.02002-02017 (2018).","DOI":"10.1128\/jvi.02002-02017"},{"key":"67969_CR71","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1128\/jvi.68.9.6069-6073.1994","volume":"68","author":"N Shimizu","year":"1994","unstructured":"Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y. & Takada, K. Isolation of Epstein\u2013Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68, 6069\u20136073 (1994).","journal-title":"J. Virol."},{"key":"67969_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01456","volume":"2","author":"A Morin","year":"2013","unstructured":"Morin, A. et al. Collaboration gets the most out of software. eLife 2, e01456 (2013).","journal-title":"eLife"},{"key":"67969_CR73","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67969-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67969-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67969-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:04:21Z","timestamp":1769792661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67969-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67969"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67969-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A.E.P., D.J.S., J.H., H.C., S.P., J.O.,\u00a0J.-L.C., B.A.P.,\u00a0J.E.L., and P.A.-B.W. are employees and possible shareholders of Vaccine Company, Inc. J.S.M. serves on the scientific advisory board and is a possible shareholder of Vaccine Company, Inc. R.S.M., C.M.A., P.O.B., M.R.S., and J.S.M. are inventors on US patent application no. 63\/689,195, entitled \u201cPrefusion-stabilized EBV gB Proteins\u201d filed by The University of Texas at Austin. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1197"}}